Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab With or Without Etaracizumab in Advanced Renal Cell Carcinoma
NCT00684996Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jun 2008
- Primary completion
- Oct 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of etaracizumab in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Jun 2008; status: terminated.
02
Drugs
etaracizumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00684996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684996.